📰 Pharma Corp News
Page 7 - Pharma Corp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Corp. Real-time updates on events, politics, business and more.
March 10, 2022
Global Janus Kinase (JAK) Inhibitors Market 2022-2026 The analyst has been monitoring the Janus kinase (JAK) inhibitors market and it is poised to grow by...
March 3, 2022
/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...
March 3, 2022
/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...
March 2, 2022
Vonjo (pacritinib) is approved to treat adults with intermediate or high-risk primary or secondary myelofibrosis with a platelet count below 50×10^9/L.
March 2, 2022
/PRNewswire/ -- The janus kinase (JAK) inhibitors market will be driven by the increasing number of awareness campaigns. The market is expected to grow by USD...
March 1, 2022
(Reuters) - CTI BioPharma Corp said on Monday the U.S. Food and Drug Administration approved its drug Vonjo (pacritinib) for treating adult patients w...
March 1, 2022
TORONTO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. (CSE: RAMM) (the “Company”). On February 22, 2022, the Company announced that, for reasons...
March 1, 2022
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has approved VONJO (pacritinib) for the...
March 1, 2022
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has approved VONJO (pacritinib) for the...
March 1, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.